Although the intestinal-type early GC samples presenting different lesions of the inflammation-carcinoma sequence in one tissue were processed into immunohistochemistry to illuminate the continuous variation of SIRT6 in this study, further research based on engineered mouse models can provide more direct evidence. This evidence concerns the gene SIRT6 and gastric cancer.